Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa

A systematic review

Jennifer Uyei, David Coetzee, James Macinko, Sally Guttmacher

Research output: Contribution to journalArticle

Abstract

Tuberculosis is a major cause of morbidity and mortality in people with HIV and about a quarter of HIV-related deaths are attributed to tuberculosis. In this Review we identify and synthesise published evidence for the effectiveness and cost-effectiveness of eight integrated strategies recommended by WHO that represent coordinated delivery of HIV and tuberculosis services. Evidence supports concurrent screening for tuberculosis and HIV, and provision of either co-trimoxazole during routine tuberculosis care or isoniazid during routine HIV care and at voluntary counselling and testing centres. Although integration of antiretroviral therapy into tuberculosis care has shown promise for improving health outcomes for patients, evidence is insufficient to make conclusive claims. Evidence is also insufficient on the accessibility of condoms at tuberculosis facilities, the benefits of risk reduction counselling in patients with tuberculosis, and the effectiveness of tuberculosis infection control in HIV health-care settings. The vertical response to the tuberculosis and HIV epidemics is ineffective and inefficient. Implications for policy makers and funders include further investments in implementing integrated tuberculosis and HIV programmes with known effectiveness, preferably in a way that strengthens health systems; evaluative research that identifies barriers to integration; and research on integrated strategies for which effectiveness, efficiency, and affordability are not well established.

Original languageEnglish (US)
Pages (from-to)855-867
Number of pages13
JournalThe Lancet Infectious Diseases
Volume11
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Africa South of the Sahara
Tuberculosis
HIV
Counseling
Isoniazid
Sulfamethoxazole Drug Combination Trimethoprim
Health
Condoms
Risk Reduction Behavior
Infection Control
Administrative Personnel
Research
Cost-Benefit Analysis
Morbidity
Delivery of Health Care
Efficiency

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa : A systematic review. / Uyei, Jennifer; Coetzee, David; Macinko, James; Guttmacher, Sally.

In: The Lancet Infectious Diseases, Vol. 11, No. 11, 11.2011, p. 855-867.

Research output: Contribution to journalArticle

@article{1fa5fce7603e43aeb831ff45c07decb1,
title = "Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: A systematic review",
abstract = "Tuberculosis is a major cause of morbidity and mortality in people with HIV and about a quarter of HIV-related deaths are attributed to tuberculosis. In this Review we identify and synthesise published evidence for the effectiveness and cost-effectiveness of eight integrated strategies recommended by WHO that represent coordinated delivery of HIV and tuberculosis services. Evidence supports concurrent screening for tuberculosis and HIV, and provision of either co-trimoxazole during routine tuberculosis care or isoniazid during routine HIV care and at voluntary counselling and testing centres. Although integration of antiretroviral therapy into tuberculosis care has shown promise for improving health outcomes for patients, evidence is insufficient to make conclusive claims. Evidence is also insufficient on the accessibility of condoms at tuberculosis facilities, the benefits of risk reduction counselling in patients with tuberculosis, and the effectiveness of tuberculosis infection control in HIV health-care settings. The vertical response to the tuberculosis and HIV epidemics is ineffective and inefficient. Implications for policy makers and funders include further investments in implementing integrated tuberculosis and HIV programmes with known effectiveness, preferably in a way that strengthens health systems; evaluative research that identifies barriers to integration; and research on integrated strategies for which effectiveness, efficiency, and affordability are not well established.",
author = "Jennifer Uyei and David Coetzee and James Macinko and Sally Guttmacher",
year = "2011",
month = "11",
doi = "10.1016/S1473-3099(11)70145-1",
language = "English (US)",
volume = "11",
pages = "855--867",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "11",

}

TY - JOUR

T1 - Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa

T2 - A systematic review

AU - Uyei, Jennifer

AU - Coetzee, David

AU - Macinko, James

AU - Guttmacher, Sally

PY - 2011/11

Y1 - 2011/11

N2 - Tuberculosis is a major cause of morbidity and mortality in people with HIV and about a quarter of HIV-related deaths are attributed to tuberculosis. In this Review we identify and synthesise published evidence for the effectiveness and cost-effectiveness of eight integrated strategies recommended by WHO that represent coordinated delivery of HIV and tuberculosis services. Evidence supports concurrent screening for tuberculosis and HIV, and provision of either co-trimoxazole during routine tuberculosis care or isoniazid during routine HIV care and at voluntary counselling and testing centres. Although integration of antiretroviral therapy into tuberculosis care has shown promise for improving health outcomes for patients, evidence is insufficient to make conclusive claims. Evidence is also insufficient on the accessibility of condoms at tuberculosis facilities, the benefits of risk reduction counselling in patients with tuberculosis, and the effectiveness of tuberculosis infection control in HIV health-care settings. The vertical response to the tuberculosis and HIV epidemics is ineffective and inefficient. Implications for policy makers and funders include further investments in implementing integrated tuberculosis and HIV programmes with known effectiveness, preferably in a way that strengthens health systems; evaluative research that identifies barriers to integration; and research on integrated strategies for which effectiveness, efficiency, and affordability are not well established.

AB - Tuberculosis is a major cause of morbidity and mortality in people with HIV and about a quarter of HIV-related deaths are attributed to tuberculosis. In this Review we identify and synthesise published evidence for the effectiveness and cost-effectiveness of eight integrated strategies recommended by WHO that represent coordinated delivery of HIV and tuberculosis services. Evidence supports concurrent screening for tuberculosis and HIV, and provision of either co-trimoxazole during routine tuberculosis care or isoniazid during routine HIV care and at voluntary counselling and testing centres. Although integration of antiretroviral therapy into tuberculosis care has shown promise for improving health outcomes for patients, evidence is insufficient to make conclusive claims. Evidence is also insufficient on the accessibility of condoms at tuberculosis facilities, the benefits of risk reduction counselling in patients with tuberculosis, and the effectiveness of tuberculosis infection control in HIV health-care settings. The vertical response to the tuberculosis and HIV epidemics is ineffective and inefficient. Implications for policy makers and funders include further investments in implementing integrated tuberculosis and HIV programmes with known effectiveness, preferably in a way that strengthens health systems; evaluative research that identifies barriers to integration; and research on integrated strategies for which effectiveness, efficiency, and affordability are not well established.

UR - http://www.scopus.com/inward/record.url?scp=82455168139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455168139&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(11)70145-1

DO - 10.1016/S1473-3099(11)70145-1

M3 - Article

VL - 11

SP - 855

EP - 867

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 11

ER -